Michael Thomas

Identification of NHLRC1 as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS)

C. Plass, A. Warth, Y. Assenov, 2022, International journal of molecular sciences.

Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles

Jeffrey M. Spraggins, H. Dienemann, R. Caprioli, 2015 .

Delft University of Technology Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma

Jeffrey M. Spraggins, T. Muley, M. Meister, 2016 .

Expression of αB‐crystallin in a mouse model of inherited retinal degeneration

M. Neal, J. Grist, C. Jomary, 1998 .

Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study

T. Welte, T. Muley, M. Meister, 2022, Frontiers in Oncology.

Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role

H Dienemann, A. Warth, H. Dienemann, 2014, British Journal of Cancer.

A Generic Data Harmonization Process for Cross-linked Research and Network Interaction

P Knaup, D Firnkorn, M Ganzinger, 2015, Methods of Information in Medicine.

Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response

J. Timmer, A. Warth, H. Dienemann, 2018, Scientific Reports.